Analyst firms · Oppenheimer · AMGN
Oppenheimer AMGN price target and rating history
Amgen Inc. (AMGN) · Health Care
Oppenheimer rates Amgen Inc. (AMGN) Outperform with a $450 price target, as of its latest action on Aug 5, 2026. It has published 3 rating actions on AMGN since February 2022, including 0 upgrades and 0 downgrades. Across 13 firms with a AMGN price target in the last 12 months, the median target is $362. Oppenheimer's $450 is 24% above that.
- Current rating
- Outperform
- Price target
- $450
- Median target, all firms
- $362
- Actions on AMGN
- 3
Oppenheimer price target on AMGN
Every Oppenheimer rating on AMGN
- Aug 5, 2026
- Apr 24, 2023
- Feb 9, 2022
How other firms rate AMGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $450 | Sep 8, 2026 |
| Truist Securities | Hold | $362 | Aug 5, 2026 |
| Oppenheimer | Outperform | $450 | Aug 5, 2026 |
| Morgan Stanley | Equal-Weight | $351 | Aug 5, 2026 |
| RBC Capital Markets | Outperform | $400 | Aug 5, 2026 |
| BofA Securities | Underperform | $317 | Aug 5, 2026 |
| Wells Fargo | Equal Weight | $400 | Aug 5, 2026 |
| Robert W. Baird | Underperform | $230 | Aug 5, 2026 |
| Canaccord Genuity | Hold | $384 | Aug 5, 2026 |
| Erste Group | Hold | May 5, 2026 | |
| Jefferies | Hold | $350 | Mar 10, 2026 |
| Barclays | Equal Weight | $185 | Feb 20, 2026 |
| Bernstein | Mkt Perform | $335 | Jan 20, 2026 |
| UBS | Buy | $380 | Jan 7, 2026 |
Questions about Oppenheimer and AMGN
- What is Oppenheimer's price target for AMGN?
- Oppenheimer's latest stated price target for Amgen Inc. (AMGN) is $450, from its action on Aug 5, 2026.
- What is Oppenheimer's rating on AMGN?
- Oppenheimer rates AMGN Outperform, a bullish rating, as of Aug 5, 2026.
- When did Oppenheimer last change its view on AMGN?
- On Aug 5, 2026, Oppenheimer raises its price target to $450 from $400, keeps Outperform.
- How does Oppenheimer's AMGN target compare with other analysts?
- Across 13 firms with a AMGN price target in the last 12 months, the median target is $362. Oppenheimer's $450 is 24% above that.
More AMGN rating histories
- BMO Capital Markets4
- Truist Securities5
- Morgan Stanley7
- RBC Capital Markets4
- BofA Securities4
- Wells Fargo5
- Barclays5
- Leerink Partners4
All Oppenheimer ratingsAMGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.